Diabetes decisions — 2025

The Board granted service connection for bladder cancer and diabetes mellitus, but remanded the issue of entitlement to service connection for prostate gland injuries with transurethral resection (TURP) postoperative residuals.

The Board remands the issue of entitlement to service connection for diabetes mellitus, type II due to a need for an addendum opinion regarding toxic exposure during service.

The Board denied service connection for bilateral hearing loss and a low back disability, but remanded claims for mental health disability, substance abuse, type two diabetes mellitus (DMII), hormonal imbalance, bilateral glaucoma, and left knee disability.

The Board granted service connection for diabetes mellitus, finding that the Veteran's diabetes was aggravated by her medication used to treat her service-connected bipolar disorder.

The Board granted service connection for a right shoulder, lumbar spine, and cervical spine disability but denied service connection for depression, hypertension, and diabetes.

The Board granted service connection for tinea pedis and bilateral foot arthritis, but denied service connection for diabetes mellitus type II. For the increase rating period from July 22, 2022, a maximum 60 percent rating for tinea versicolor was granted.

The Board denied service connection for diabetes mellitus as the evidence did not support a finding that it began during active service or was related to an in-service injury, event, or disease.

The Board granted service connection for the cause of the Veteran's death, finding that his death was due to conditions caused by exposure to herbicide agents while serving aboard the U.S.S. Ticonderoga.

The Board granted an effective date of February 16, 2008, for the grant of service connection for diabetes mellitus type II.

The Board remands the claims for increased ratings and TDIU due to the need for a contemporaneous VA examination given the Veteran's contentions of worsening symptoms and the lapse in time since the last examinations.

The Board remands the claims for service connection for hypertension and diabetes mellitus, type II to obtain additional medical opinions addressing the theories of secondary service connection.

The Board granted service connection for the cause of death, finding that diabetes mellitus was related to the Veteran's military service and contributed to his primary causes of death.

The Board granted a 100 percent rating for chronic renal disease with nephrolithiasis and hypertension from March 26, 2019, but no earlier.

The Board remands the claims for service connection for multiple myeloma, heart disease, and diabetes mellitus due to insufficient evidence of in-service exposure to herbicide agents.

The Board granted service connection for diabetes mellitus, type II, as secondary to the Veteran's service-connected hypertension.

The Board granted service connection for prostate cancer and type II diabetes mellitus under the PACT Act, but remanded the claim for chronic kidney disease.

The Board remands the claims for service connection for cause of death and diabetes mellitus, type I to ensure complete service records are associated with the claims folder and to obtain necessary medical opinions.

The Board granted service connection for type II diabetes mellitus and remanded the claim for heart disease due to insufficient evidence.

The appeal was dismissed for service connection claims of pancreatitis, diabetes mellitus, and TDIU. The claim for a bilateral knee disability was denied, while the claims for hypertension and sleep apnea were remanded.

The Board remands the claims for service connection, a higher disability rating for PTSD, and TDIU due to outstanding medical records that need to be obtained.